Saroglitazar for the treatment of dyslipidemia in diabetic patients.
about
Peroxisome Proliferator-Activated Receptors in Female Reproduction and FertilityDiabetes DyslipidemiaPPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar.Fibrates in the management of atherogenic dyslipidemia.Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
P2860
Q26738962-E8A68A46-3872-4F8E-A51D-CC60E142B052Q26750905-F5A79A4C-E12A-4A72-B0FD-1EAAF4745DB1Q30241952-B1168837-E229-43FF-A85E-FC0D08EE27E5Q38674742-D046CC14-75A7-4017-98CD-F8E368D669DCQ47400859-0842CF4C-F9C3-4FA5-A091-2649AD95F4F7Q49571281-6D41A748-11FF-47B5-A982-CE76BA381E52Q49819768-07FDAECA-A9A1-4683-8EF6-B2D65331A9AC
P2860
Saroglitazar for the treatment of dyslipidemia in diabetic patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Saroglitazar for the treatment of dyslipidemia in diabetic patients.
@en
type
label
Saroglitazar for the treatment of dyslipidemia in diabetic patients.
@en
prefLabel
Saroglitazar for the treatment of dyslipidemia in diabetic patients.
@en
P2860
P1476
Saroglitazar for the treatment of dyslipidemia in diabetic patients.
@en
P2093
Shashank R Joshi
P2860
P304
P356
10.1517/14656566.2015.1009894
P407
P577
2015-03-01T00:00:00Z